SGFrench software company Dassault Systèmes confirmed its financial outlook for 2026 after reporting second-quarter revenue that met expectations. The company announced the acquisition of U.S.-based ArisGlobal, a life sciences software provider, for approximately $1.8 billion in cash, with potential additional payments linked to AI-related revenue goals. The deal aims to strengthen Dassault’s position in AI-driven life sciences software, particularly as pharmaceutical companies seek to accelerate clinical development and regulatory processes. While Dassault’s Life Sciences division faced revenue declines, its core industrial software business saw strong growth, especially in cloud-based solutions. The acquisition is expected to boost revenue and earnings per share within a year of completion, though it depends on regulatory approval.
Bias read (Center): The article focuses on corporate strategy, financial performance, and market expansion, with no mention of political figures, policies, or ideological stances. It provides factual information about a business acquisition and financial projections without apparent bias or framing that favors any side
